Navigation Links
Survey: Migraine Patients Taking Potentially Addictive Barbiturate,or Opioid Medications Not Approved by FDA as Migraine Treatments

y the FDA to treat the disease.

Some migraine patients mistakenly think their medication is not addictive: 36 percent of patients taking barbiturates or opioids as their primary migraine prescription medication said the phrase "not addictive" describes their medication "extremely" or "very" well, according to the survey.

Few physicians surveyed prescribe barbiturates or opioids (2% and 1% respectively) as a first-line acute treatment for migraines, but general practitioners are more likely than neurologists to prescribe opioids as a second-line treatment, the survey found. Twenty-five percent of general practitioners say they would prescribe opioids as a second-line therapy for migraines, compared with just 7 percent of neurologists.

"Though it's encouraging that the survey showed 53 percent of migraine patients are now on triptans, an approved drug class, the fact that 20 percent of patients continue to take medications unapproved to treat migraine indicates that additional physician education could be helpful" said Suzanne Simons, executive director of the National Headache Foundation.

Simple Steps to Achieving Optimal Migraine Treatment

While there is no cure for migraines, taking the right medication below to effectively treat your migraine will minimize how they affect your daily life. Here are a few steps you can take to help optimize your migraine treatment.

    -- Observe. Make note of any side effects that you experience from your

       migraine medication which may affect your daily activities.

    -- Communicate. Keep a headache journal or diary. The journal may include

       when the headache occurred, its severity, duration, location and

       whether the medication you took to treat it was effective. You can

       download a free headache diary at http://www.headaches.org

    -- Use self-management techniques -- There are ways to manage your

'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
2. Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
3. NuPathe Reports Positive Phase One Results for NP101 Transdermal Therapy for Acute Migraine
4. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
5. Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both Traditional and Non-traditional Migraine Symptoms
6. Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks
7. Addex Reports Positive Results in Phase IIa Clinical Trial With ADX10059 in Migraine
8. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
9. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
10. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:5/6/2015)... SAN FRANCISCO , May 6, 2015 /PRNewswire/ ... (MZEI:OB, MZEI:QB), manufacturers of the AsepticSure® Hospital Disinfection ... indicators used to confirm medical instrument sterilization in ...   absolute bactericidal kill for hospital room disinfection. ... process indicators that can directly monitor the lethality ...
(Date:5/6/2015)... -- Eli Lilly and Company (NYSE: LLY ) ... and device innovation center in Cambridge, Massachusetts ... attract top scientists and bioengineers, as well as enhance ... Lilly Cambridge Innovation Center, a makerspace located in Kendall ... to explore how emerging technologies and connectivity can advance ...
(Date:5/6/2015)... , May 6, 2015   Sigma-Aldrich Corporation (NASDAQ: ... technology company, today announced a $50,000 product donation to ... initiative to replicate key findings from recent high-impact papers ... a collaboration between the online research marketplace Science ... and the open-access journal eLife. The ...
Breaking Medicine Technology:Hospital Rooms Cleaned to Autoclave Standards 2Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts 2Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts 3Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 2Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 3
... BURLINGTON, Vt., Feb. 6, 2012  After only three years ... Award from the International Society for Optics and Photonics ... products in the category of  "Life Sciences and Biophotonics." ... a patent-pending, innovative, high-intensity and exceptionally stable new light ...
... Pharmaceuticals, Inc. (NASDAQ: CADX ), a biopharmaceutical ... principally for use in the hospital setting, announced today ... (acetaminophen) injection. Cadence has notified the U.S. Food and ... recall of OFIRMEV lot number V005710 was initiated due ...
Cached Medicine Technology:89 North Wins Prestigious International Award 2Cadence Pharmaceuticals Announces Voluntary Recall of One Lot of OFIRMEV® (Acetaminophen) Injection 2Cadence Pharmaceuticals Announces Voluntary Recall of One Lot of OFIRMEV® (Acetaminophen) Injection 3Cadence Pharmaceuticals Announces Voluntary Recall of One Lot of OFIRMEV® (Acetaminophen) Injection 4
(Date:5/6/2015)... May 06, 2015 The Florida Council ... Health Coalition, Group Victory, Miami Area Geriatric Education Center, ... of Broward County Commission on Substance Abuse, will hold ... May 12-14, at the Riverside Hotel. , This important ... education for everyone as well as clinical training for ...
(Date:5/6/2015)... york, NY (PRWEB) May 06, 2015 ... strategy, design, creative and technology, announced today that its ... expert advisor by Shocase, a marketing professional network aimed ... marketing sector. , Widely regarded as a specialist in ... the most high-profile branding programs over the last three ...
(Date:5/6/2015)... In celebration of their twentieth anniversary, Premierlacewigs.com launched ... away a deluxe human hair lace wig valued at $300 ... on a third-party giveaway tool. The important thing is the ... winner. , The hair is a crown, a reflection of ... a jewel for the past 20 years. Whether it is ...
(Date:5/6/2015)... May 06, 2015 Most people in the ... nursing or other care after age 65. But less than ... for it or even talking about it, reports the May ... people risk two problems. One is losing control over the ... families," says Dr. David Grabowski, a professor of health care ...
(Date:5/6/2015)... 06, 2015 Doctors who have done ... they are calling “unprecedented” tumor control in mesothelioma patients. ... new research. Click here to read it now. ... 25 mesothelioma patients between March and December 2014. They ... , “Pembrolizumab… provides robust antitumor activity in patients with ...
Breaking Medicine News(10 mins):Health News:Conference on Problem Gambling to be held in Ft. Lauderdale, FL 2Health News:Shocase Selects MBLM’s Claude Salzberger as Company Advisor 2Health News:PremierLaceWigs.com Human Hair Lace Wigs Giveaway Could Change Your Hairstyle 2Health News:Start Planning Now for Long-Term Care, from the May 2015 Harvard Health Letter 2Health News:Researchers Say “Unprecedented” Mesothelioma Response Possible with Skin Cancer Drug, According to Surviving Mesothelioma 2
... Scientists at Warwick Medical School have uncovered the molecular ... ,health checkpoint, with cells that carry unequal numbers of ... , Studying simple yeast cells, scientists now understand the ... the correct number of chromosomes. , Most ...
... State University will lead a four-year, $5 million expanded ... discover proteins, or biomarkers, to help predict cardiovascular disease ... type 2 diabetes. Nearly 26 million Americans have ... U.S. The disease is a major cause of heart ...
... , TUESDAY, Nov. 1 (HealthDay News) -- Multiple sclerosis ... aim at the abnormal behavior of a specific type of ... the cells in question -- known as "B cells" -- ... and disabling nervous system disease, commonly called MS. The ...
... high school students are considered overweight, and while a myriad ... parents can do to help curb these rates, very little ... lose weight. Research led by public health doctoral candidate ... Philadelphia report wanting to lose weight, their actions are more ...
... an eight hour shift leads to substantial cost savings and energy ... Journal of the American College of Radiology . ... the use of computers and scanning equipment. "We should ... this equipment and look for ways to reduce it, both as ...
... NYU Langone Medical Center identified for the first time that ... outer and inner layers of the brain, called "blurring", may ... development of new therapies for degenerative brain conditions, such as ... issue of the Journal of Neuroscience . ...
Cached Medicine News:Health News:Warwick scientists discover how daughter cells receive the same number of chromosomes 2Health News:ASU leads $5 million NIH-sponsored research initiative to advance diabetes care and treatment 2Health News:ASU leads $5 million NIH-sponsored research initiative to advance diabetes care and treatment 3Health News:New Multiple Sclerosis Therapy Promising in Early Trial 2Health News:New Multiple Sclerosis Therapy Promising in Early Trial 3Health News:Study finds overweight teens want to lose weight, going about it the wrong way 2Health News:Neurologists identify potential biomarker of cognitive decline for earlier diagnosis of disease 2
Illuminated Phoroptor Refracting Instrument. Illumination is provided by a cool-running, energy efficient LEDs (Light Emitting Diodes) that light only what you need to see without affecting the darke...
Occluder and Maddox Rod...
Graham Field 10' Reversed Snellen Eye Chart....
Ultrasonic Pachymeter UP-1000 is fast, accurate corneal thickness measurements....
Medicine Products: